{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T01:51:29Z","timestamp":1775267489807,"version":"3.50.1"},"reference-count":42,"publisher":"Baishideng Publishing Group Inc.","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2009]]},"DOI":"10.3748\/wjg.15.2433","type":"journal-article","created":{"date-parts":[[2009,5,27]],"date-time":"2009-05-27T04:11:27Z","timestamp":1243397487000},"page":"2433","source":"Crossref","is-referenced-by-count":46,"title":["Non-invasive biomarkers for monitoring the fibrogenic process in liver: A short survey"],"prefix":"10.3748","volume":"15","author":[{"given":"Axel M","family":"Gressner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Fang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olav A","family":"Gressner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2060","reference":[{"key":"ref1","unstructured":"Schuppan D, Gressner AM. Function and metabolism of collagens and other extracellular matrix proteins. Oxford textbook of clinical hepatology Oxford Medical Publications: Oxford; 1999;381-407."},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Gressner OA, Rizk MS, Kovalenko E, Weiskirchen R, Gressner AM. Changing the pathogenetic roadmap of liver fibrosis? Where did it start; where will it go? J Gastroenterol Hepatol 2008;23:1024-1035.","DOI":"10.1111\/j.1440-1746.2008.05345.x"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Gressner AM, Weiskirchen R. Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. J Cell Mol Med 2006;10:76-99.","DOI":"10.1111\/j.1582-4934.2006.tb00292.x"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology 2008;134:1655-1669.","DOI":"10.1053\/j.gastro.2008.03.003"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Zeisberg M, Yang C, Martino M, Duncan MB, Rieder F, Tanjore H, Kalluri R. Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J Biol Chem 2007;282:23337-23347.","DOI":"10.1074\/jbc.M700194200"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Diaz R, Kim JW, Hui JJ, Li Z, Swain GP, Fong KS, Csiszar K, Russo PA, Rand EB, Furth EE. Evidence for the epithelial to mesenchymal transition in biliary atresia fibrosis. Hum Pathol 2008;39:102-115.","DOI":"10.1016\/j.humpath.2007.05.021"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Kaimori A, Potter J, Kaimori JY, Wang C, Mezey E, Koteish A. Transforming growth factor-beta1 induces an epithelial-to-mesenchymal transition state in mouse hepatocytes in vitro. J Biol Chem 2007;282:22089-22101.","DOI":"10.1074\/jbc.M700998200"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Russo FP, Alison MR, Bigger BW, Amofah E, Florou A, Amin F, Bou-Gharios G, Jeffery R, Iredale JP, Forbes SJ. The bone marrow functionally contributes to liver fibrosis. Gastroenterology 2006;130:1807-1821.","DOI":"10.1053\/j.gastro.2006.01.036"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Forbes SJ, Russo FP, Rey V, Burra P, Rugge M, Wright NA, Alison MR. A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis. Gastroenterology 2004;126:955-963.","DOI":"10.1053\/j.gastro.2004.02.025"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Kinoshita K, Iimuro Y, Otogawa K, Saika S, Inagaki Y, Nakajima Y, Kawada N, Fujimoto J, Friedman SL, Ikeda K. Adenovirus-mediated expression of BMP-7 suppresses the development of liver fibrosis in rats. Gut 2007;56:706-714.","DOI":"10.1136\/gut.2006.092460"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003;38:1449-1457.","DOI":"10.1053\/jhep.2003.09022"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 2008;88:125-172.","DOI":"10.1152\/physrev.00013.2007"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Collazos J, Diaz F. Role of the measurement of serum procollagen type III N-terminal peptide in the evaluation of liver diseases. Clin Chim Acta 1994;227:37-43.","DOI":"10.1016\/0009-8981(94)90133-3"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Lydatakis H, Hager IP, Kostadelou E, Mpousmpoulas S, Pappas S, Diamantis I. Non-invasive markers to predict the liver fibrosis in non-alcoholic fatty liver disease. Liver Int 2006;26:864-871.","DOI":"10.1111\/j.1478-3231.2006.01312.x"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Kropf J, Gressner AM, Tittor W. Logistic-regression model for assessing portal hypertension by measuring hyaluronic acid (hyaluronan) and laminin in serum. Clin Chem 1991;37:30-35.","DOI":"10.1093\/clinchem\/37.1.30"},{"key":"ref16","unstructured":"Flisiak R, Maxwell P, Prokopowicz D, Timms PM, Panasiuk A. Plasma tissue inhibitor of metalloproteinases-1 and transforming growth factor beta 1--possible non-invasive biomarkers of hepatic fibrosis in patients with chronic B and C hepatitis. Hepatogastroenterology 2002;49:1369-1372."},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Roth S, Michel K, Gressner AM. (Latent) transforming growth factor beta in liver parenchymal cells, its injury-dependent release, and paracrine effects on rat hepatic stellate cells. Hepatology 1998;27:1003-1012.","DOI":"10.1002\/hep.510270416"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Gressner AM, Yagmur E, Lahme B, Gressner O, Stanzel S. Connective tissue growth factor in serum as a new candidate test for assessment of hepatic fibrosis. Clin Chem 2006;52:1815-1817.","DOI":"10.1373\/clinchem.2006.070466"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Gressner OA, Gressner AM. Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseases. Liver Int 2008;28:1065-1079.","DOI":"10.1111\/j.1478-3231.2008.01826.x"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Gressner OA, Lahme B, Demirci I, Gressner AM, Weiskirchen R. Differential effects of TGF-beta on connective tissue growth factor (CTGF\/CCN2) expression in hepatic stellate cells and hepatocytes. J Hepatol 2007;47:699-710.","DOI":"10.1016\/j.jhep.2007.05.015"},{"key":"ref21","unstructured":"Johansen JS. Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer. Dan Med Bull 2006;53:172-209."},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Saitou Y, Shiraki K, Yamanaka Y, Yamaguchi Y, Kawakita T, Yamamoto N, Sugimoto K, Murata K, Nakano T. Noninvasive estimation of liver fibrosis and response to interferon therapy by a serum fibrogenesis marker, YKL-40, in patients with HCV-associated liver disease. World J Gastroenterol 2005;11:476-481.","DOI":"10.3748\/wjg.v11.i4.476"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Tran A, Benzaken S, Saint-Paul MC, Guzman-Granier E, Hastier P, Pradier C, Barjoan EM, Demuth N, Longo F, Rampal P. Chondrex (YKL-40), a potential new serum fibrosis marker in patients with alcoholic liver disease. Eur J Gastroenterol Hepatol 2000;12:989-993.","DOI":"10.1097\/00042737-200012090-00004"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Halfon P, Munteanu M, Poynard T. FibroTest-ActiTest as a non-invasive marker of liver fibrosis. Gastroenterol Clin Biol 2008;32:22-39.","DOI":"10.1016\/S0399-8320(08)73991-5"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Poynard T, Imbert-Bismut F, Munteanu M, Messous D, Myers RP, Thabut D, Ratziu V, Mercadier A, Benhamou Y, Hainque B. Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C. Comp Hepatol 2004;3:8.","DOI":"10.1186\/1476-5926-3-8"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, Lok AS. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003;38:518-526.","DOI":"10.1053\/jhep.2003.50346"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Rosenberg WM, Voelker M, Thiel R, Becka M, Burt A, Schuppan D, Hubscher S, Roskams T, Pinzani M, Arthur MJ. Serum markers detect the presence of liver fibrosis: a cohort study. Gastroenterology 2004;127:1704-1713.","DOI":"10.1053\/j.gastro.2004.08.052"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Adams LA, Bulsara M, Rossi E, DeBoer B, Speers D, George J, Kench J, Farrell G, McCaughan GW, Jeffrey GP. Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection. Clin Chem 2005;51:1867-1873.","DOI":"10.1373\/clinchem.2005.048389"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Poynard T, Ratziu V, Naveau S, Thabut D, Charlotte F, Messous D, Capron D, Abella A, Massard J, Ngo Y. The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis. Comp Hepatol 2005;4:10.","DOI":"10.1186\/1476-5926-4-10"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Parkes J, Guha IN, Roderick P, Rosenberg W. Performance of serum marker panels for liver fibrosis in chronic hepatitis C. J Hepatol 2006;44:462-474.","DOI":"10.1016\/j.jhep.2005.10.019"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Sebastiani G, Vario A, Guido M, Noventa F, Plebani M, Pistis R, Ferrari A, Alberti A. Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C. J Hepatol 2006;44:686-693.","DOI":"10.1016\/j.jhep.2006.01.007"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Cales P, de Ledinghen V, Halfon P, Bacq Y, Leroy V, Boursier J, Foucher J, Bourliere M, de Muret A, Sturm N. Evaluating the accuracy and increasing the reliable diagnosis rate of blood tests for liver fibrosis in chronic hepatitis C. Liver Int 2008;28:1352-1362.","DOI":"10.1111\/j.1478-3231.2008.01789.x"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Paggi S, Colli A, Fraquelli M, Vigano M, Del Poggio P, Facciotto C, Colombo M, Ronchi G, Conte D. A non-invasive algorithm accurately predicts advanced fibrosis in hepatitis C: a comparison using histology with internal-external validation. J Hepatol 2008;49:564-571.","DOI":"10.1016\/j.jhep.2008.07.007"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Rosenthal-Allieri MA, Peritore ML, Tran A, Halfon P, Benzaken S, Bernard A. Analytical variability of the Fibrotest proteins. Clin Biochem 2005;38:473-478.","DOI":"10.1016\/j.clinbiochem.2004.12.012"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Quan TE, Cowper S, Wu SP, Bockenstedt LK, Bucala R. Circulating fibrocytes: collagen-secreting cells of the peripheral blood. Int J Biochem Cell Biol 2004;36:598-606.","DOI":"10.1016\/j.biocel.2003.10.005"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Kubota A, Okamura S, Omori F, Shimoda K, Otsuka T, Ishibashi H, Niho Y. High serum levels of granulocyte-macrophage colony-stimulating factor in patients with liver cirrhosis and granulocytopenia. Clin Lab Haematol 1995;17:61-63.","DOI":"10.1111\/j.1365-2257.1995.tb00319.x"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Tacke F, Gabele E, Bataille F, Schwabe RF, Hellerbrand C, Klebl F, Straub RH, Luedde T, Manns MP, Trautwein C. Bone morphogenetic protein 7 is elevated in patients with chronic liver disease and exerts fibrogenic effects on human hepatic stellate cells. Dig Dis Sci 2007;52:3404-3415.","DOI":"10.1007\/s10620-007-9758-8"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Kuhn J, Prante C, Schon S, Gotting C, Kleesiek K. Measurement of fibrosis marker xylosyltransferase I activity by HPLC electrospray ionization tandem mass spectrometry. Clin Chem 2006;52:2243-2249.","DOI":"10.1373\/clinchem.2006.071167"},{"key":"ref39","unstructured":"Gressner AM. Activation of proteoglycan synthesis in injured liver--a brief review of molecular and cellular aspects. Eur J Clin Chem Clin Biochem 1994;32:225-237."},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Poon TC, Hui AY, Chan HL, Ang IL, Chow SM, Wong N, Sung JJ. Prediction of liver fibrosis and cirrhosis in chronic hepatitis B infection by serum proteomic fingerprinting: a pilot study. Clin Chem 2005;51:328-335.","DOI":"10.1373\/clinchem.2004.041764"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Callewaert N, Van Vlierberghe H, Van Hecke A, Laroy W, Delanghe J, Contreras R. Noninvasive diagnosis of liver cirrhosis using DNA sequencer-based total serum protein glycomics. Nat Med 2004;10:429-434.","DOI":"10.1038\/nm1006"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Mardini H, Record C. Detection assessment and monitoring of hepatic fibrosis: biochemistry or biopsy? Ann Clin Biochem 2005;42:441-447.","DOI":"10.1258\/000456305774538210"}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v15\/i20\/2433.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T19:24:06Z","timestamp":1589829846000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v15\/i20\/2433.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"references-count":42,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.3748\/wjg.15.2433","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2009]]}}}